WEDGE CAPITAL MANAGEMENT L L P/NC
Position in PCRX — Pacira BioSciences, Inc.
CIK 1015308
CHARLOTTE, NC
Position in PCRX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,398,834
+$601,157 QoQ
Shares Held
94,554
-20.8% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#60
of 251 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $47,806,751 across 8 Drug Manufacturers - Specialty & Generic names. PCRX ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,856,208 | $29,476,583 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
380,801 | $3,808,010 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
68,885 | $3,203,841 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
61,203 | $2,893,065 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
71,523 | $2,589,132 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
This page
|
94,554 | $2,398,834 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
435,650 | $1,834,086 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
19,367 | $1,603,200 |
All Filings in PCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,398,834 | 94,554 | Shares | Sole | 2026-07-10 | |
| 2024-09-30 | $1,797,677 | 119,447 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $1,473,415 | 51,500 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,647,511 | 56,383 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,059,908 | 31,414 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||